RESISTANCE TO FEVER INDUCTION AND IMPAIRED ACUTE-PHASE RESPONSE IN INTERLEUKIN-1-BETA-DEFICIENT MICE

被引:321
作者
ZHENG, H
FLETCHER, D
KOZAK, W
JIANG, MH
HOFMANN, KJ
CONN, CA
SOSZYNSKI, D
GRABIEC, C
TRUMBAUER, ME
SHAW, A
KOSTURA, MJ
STEVENS, K
ROSEN, H
NORTH, RJ
CHEN, HY
TOCCI, MJ
KLUGER, MJ
VANDERPLOEG, LHT
机构
[1] MERCK RES LABS,DEPT IMMUNOL & INFLAMMAT,RAHWAY,NJ 07065
[2] MERCK RES LABS,LAB ANIM RESOURCES,RAHWAY,NJ 07065
[3] LOVELACE INST,INST BASIC & APPL MED RES,ALBUQUERQUE,NM 87108
[4] MERCK RES LABS,DEPT VIRUS & CELL BIOL,W POINT,PA 19486
[5] TRUDEAU INST INC,SARANAC LAKE,NY 12983
关键词
D O I
10.1016/1074-7613(95)90154-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We used gene targeting in embryonic stem cells to introduce an IL-1 beta null allele in mice. The IL-1 beta-deficient mice develop normally and are apparently healthy and fertile. The IL-1 beta null mice responded normally in models of contact and delayed-type hypersensitivity or following bacterial endotoxin LPS-induced inflammation. The IL-1 beta-deficient mice showed equivalent resistance to Listeria monocytogenes compared with wild-type controls. In contrast, when challenged with turpentine, which causes localized inflammation and tissue injury, the IL-1 beta mutant mice exhibited an impaired acute-phase inflammatory response and were completely resistant to fever development and anorexia. These results highlight a central role for IL-1 beta as a pyrogen and a mediator of the acute-phase response in a subset of inflammatory disease models, and support the notion that blocking the action of a single key cytokine can alter the course of specific immune and inflammatory responses.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 63 条
[1]   BIOLOGY OF MULTIFUNCTIONAL CYTOKINES - IL-6 AND RELATED MOLECULES (IL-1 AND TNF) [J].
AKIRA, S ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
FASEB JOURNAL, 1990, 4 (11) :2860-2867
[2]   A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION [J].
ALCAMI, A ;
SMITH, GL .
CELL, 1992, 71 (01) :153-167
[3]   INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[4]  
ASHERSON GL, 1968, IMMUNOLOGY, V15, P405
[5]   REGULATION OF MAJOR ACUTE-PHASE PLASMA-PROTEINS BY HEPATOCYTE-STIMULATING FACTORS OF HUMAN SQUAMOUS CARCINOMA-CELLS [J].
BAUMANN, H ;
HILL, RE ;
SAUDER, DN ;
JAHREIS, GP .
JOURNAL OF CELL BIOLOGY, 1986, 102 (02) :370-383
[6]   METABOLIC RESPONSE TO INFECTION [J].
BEISEL, WR .
ANNUAL REVIEW OF MEDICINE, 1975, 26 :9-20
[7]   INTERLEUKIN-1 IMMUNOREACTIVE INNERVATION OF THE HUMAN HYPOTHALAMUS [J].
BREDER, CD ;
DINARELLO, CA ;
SAPER, CB .
SCIENCE, 1988, 240 (4850) :321-324
[8]  
BRODY DT, 1989, J IMMUNOL, V143, P1183
[9]   PURIFICATION TO HOMOGENEITY AND AMINO-ACID SEQUENCE-ANALYSIS OF 2 ANIONIC SPECIES OF HUMAN INTERLEUKIN-1 [J].
CAMERON, PM ;
LIMJUCO, GA ;
CHIN, J ;
SILBERSTEIN, L ;
SCHMIDT, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :237-250
[10]   MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME [J].
CERRETTI, DP ;
KOZLOSKY, CJ ;
MOSLEY, B ;
NELSON, N ;
VANNESS, K ;
GREENSTREET, TA ;
MARCH, CJ ;
KRONHEIM, SR ;
DRUCK, T ;
CANNIZZARO, LA ;
HUEBNER, K ;
BLACK, RA .
SCIENCE, 1992, 256 (5053) :97-100